{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T16:27:49Z","timestamp":1772814469883,"version":"3.50.1"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[1994,1,1]],"date-time":"1994-01-01T00:00:00Z","timestamp":757382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":9502,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[1994]]},"DOI":"10.1093\/annonc\/5.suppl_4.s31","type":"journal-article","created":{"date-parts":[[2012,11,19]],"date-time":"2012-11-19T21:56:56Z","timestamp":1353362216000},"page":"S31-S37","source":"Crossref","is-referenced-by-count":9,"special_numbering":"S4","title":["Molecular biology of breast cancer"],"prefix":"10.1016","volume":"5","author":[{"given":"N.R.","family":"Lemoine","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0060","first-page":"1231","article-title":"Linkage of familial breast cancer to chromosome 17q21 may not be restricted to early onset disease","volume":"50","author":"Margaritte","year":"1992","journal-title":"Am J Hum Genet"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0065","first-page":"678","article-title":"The Breast Cancer Linkage Consortium. Genetic linkage analysis is familial breast and ovarian cancer - results from 214 families","volume":"52","author":"Easton","year":"1993","journal-title":"Am J Hum Genet"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0070","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1126\/science.2270482","article-title":"Linkage of early-onset familial breast cancer to chromosome 17q21","volume":"250","author":"Hall","year":"1990","journal-title":"Science"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0075","first-page":"82","article-title":"Familial breast-ovarian cancer locus on chromosome 17q21\u2013q23","volume":"ii","author":"Narod","year":"1991","journal-title":"Lancet"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0080","first-page":"718","article-title":"Thral and d17s183 flank an interval of less-than-4 cm for the breast-ovarian cancer gene (brcal) on chromosome-17q21","volume":"52","author":"Bowcock","year":"1993","journal-title":"Am J Hum Genet"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0085","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0168-9525(93)90068-S","article-title":"The search for the familial breast\/ ovarian cancer gene","volume":"9","author":"Black","year":"1993","journal-title":"Trends Genet"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0090","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.8430309","article-title":"Zeroing in on a breast cancer susceptibility gene","volume":"259","author":"Roberts","year":"1993","journal-title":"Science"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0095","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/ng1092-128","article-title":"Allele losses in the region 17q12\u201321 in familial breast and ovarian cancer involve the wild-type chromosome","volume":"2","author":"Smith","year":"1992","journal-title":"Nature Genet"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0100","first-page":"2624","article-title":"Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsatellite length polymorphisms","volume":"52","author":"Futreal","year":"1992","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0105","first-page":"781","article-title":"Allele loss patterns on chromosome 17q in 109 breast carcinomas indicate at least two distinct target regions","volume":"8","author":"Cornelis","year":"1993","journal-title":"Oncogene"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0110","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/BF00230213","article-title":"Four separate regions in chromosome 17 show loss of heterozygosity in familial breast carcinomas","volume":"91","author":"Lindblom","year":"1993","journal-title":"Hum Genet"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0115","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/0140-6736(93)92468-9","article-title":"Increasing incidence of breast cancer in family with BRCA1 mutation","volume":"341","author":"Narod","year":"1993","journal-title":"Lancet"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0120","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0140-6736(93)90052-I","article-title":"Breast cancer survival in BRCA1 carriers","volume":"341","author":"Porter","year":"1993","journal-title":"Lancet"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0125","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1128\/MCB.11.3.1372","article-title":"Prohibitin, an evolutionarily conserved intracellular protein that blocks DNA synthesis in normal fibroblasts and Hela cells","volume":"11","author":"Nuell","year":"1991","journal-title":"Mol Cell Biol"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0130","first-page":"5794","article-title":"Accumulation of genetic alterations and progression of primary breast cancer","volume":"51","author":"Sato","year":"1992","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0135","first-page":"2490","article-title":"Somatic allelic deletion of nm23 in human cancer","volume":"51","author":"Leone","year":"1991","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0140","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/gcc.2870040203","article-title":"Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p and 17q in human breast carcinomas","volume":"4","author":"Andersen","year":"1992","journal-title":"Genes Chrom Cancer"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0145","first-page":"5185","article-title":"Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential","volume":"49","author":"Bevilacqua","year":"1989","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0150","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/jnci\/83.4.281","article-title":"Expression of the antimetastatic gene nm23 in human breast cancer An association with good prognosis","volume":"83","author":"Hennessy","year":"1991","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0155","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/jnci\/85.9.727","article-title":"nm23 product expression in in situ and invasive human breast cancer","volume":"85","author":"Royds","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0160","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF00662142","article-title":"nm23 and breast cancer metastasis","volume":"25","author":"Steeg","year":"1993","journal-title":"Breast Cancer Res Treat"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0165","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1126\/science.1905840","article-title":"p53 mutations in human cancers","volume":"253","author":"Hollstein","year":"1991","journal-title":"Science"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0170","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/351453a0","article-title":"The p53 tumour suppressor gene","volume":"351","author":"Levine","year":"1991","journal-title":"Nature"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0175","first-page":"725","article-title":"The retinoblastoma gene is frequently altered leading to loss of expression in primary breast tumours","volume":"4","author":"Varley","year":"1989","journal-title":"Oncogene"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0180","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/bjc.1991.44","article-title":"Mutations in p53 do not account for heritable breast cancer: A study in five affected families","volume":"63","author":"Prosser","year":"1991","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0185","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/0140-6736(90)93236-I","article-title":"Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis","volume":"336","author":"Coles","year":"1990","journal-title":"Lancet"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0190","first-page":"5291","article-title":"p53 mutations in breast cancer","volume":"52","author":"Coles","year":"1992","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0195","first-page":"2605","article-title":"Maintenance of p53 alterations throughout breast cancer progression","volume":"51","author":"Davidoff","year":"1991","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0200","doi-asserted-by":"crossref","first-page":"5006","DOI":"10.1073\/pnas.88.11.5006","article-title":"Genetic basis for p53 overexpression in human breast cancer","volume":"88","author":"Davidoff","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0205","first-page":"413","article-title":"Loss of chromosome 17q13 sequences and mutation of p53 in human breast carcinomas","volume":"6","author":"Varley","year":"1991","journal-title":"Oncogene"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0210","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/BF00202481","article-title":"Human breast cancer: Frequent p53 allele loss and protein overexpression","volume":"90","author":"Singh","year":"1993","journal-title":"Hum Genet"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0215","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/ijc.2910410204","article-title":"p53 expression in breast cancer","volume":"41","author":"Cattoretti","year":"1988","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0220","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/jnci\/84.11.845","article-title":"Accumulation of p53 tumour suppressor gene protein: An independent marker of prognosis in breast cancer","volume":"84","author":"Thor","year":"1992","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0225","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/path.1711650303","article-title":"Expression of p53 protein in infiltrating and in situ breast carcinomas","volume":"165","author":"Walker","year":"1991","journal-title":"J Pathol"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0230","doi-asserted-by":"crossref","first-page":"7262","DOI":"10.1073\/pnas.89.15.7262","article-title":"Two distinct mechanisms alter p53 in breast cancer Mutation and nuclear exclusion","volume":"89","author":"Moll","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0235","first-page":"669","article-title":"Nuclear p53 protein accumulates preferentially in medullary and high-grade ductal but rarely in lobular breast carcinomas","volume":"142","author":"Domagala","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0240","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1073\/pnas.89.8.3439","article-title":"Immune response to p53 is dependent upon p53\/HSP70 complexes in breast cancer","volume":"89","author":"Davidoff","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0245","first-page":"6380","volume":"52","author":"Schlichtholz","year":"1992","journal-title":"The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot Cancer Res"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0250","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1093\/jnci\/84.14.1109","article-title":"Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients","volume":"84","author":"Isola","year":"1992","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0255","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/jnci\/85.3.200","article-title":"Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer","volume":"85","author":"Allred","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0260","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/jnci\/85.12.965","article-title":"p53 as an independent prognostic marker in lymph node-negative breast cancer patients","volume":"85","author":"Silvestrini","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0265","first-page":"1637","article-title":"Somatic p53 mutations in human breast carcinomas in an Icelandic population: A prognostic factor","volume":"53","author":"Thorlacius","year":"1993","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0270","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1126\/science.1978757","article-title":"Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms","volume":"250","author":"Malkin","year":"1990","journal-title":"Science"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0275","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/348747a0","article-title":"Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni Syndrome","volume":"348","author":"Srivastrava","year":"1990","journal-title":"Nature"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0280","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/BF00217135","article-title":"Absence of p53 germ-line mutations in bilateral breast cancer patients","volume":"89","author":"Lidereau","year":"1992","journal-title":"Hum Genet"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0285","first-page":"2984","article-title":"Inherited p53 gene mutations in breast cancer","volume":"52","author":"Sidransky","year":"1992","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0290","first-page":"1043","article-title":"No evidence for germline mutations in exons 5\u20139 of the p53 gene in 25 breast cancer families","volume":"7","author":"Warren","year":"1992","journal-title":"Oncogene"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0295","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1126\/science.3388033","article-title":"Inactivation of the retinoblastoma susceptibility gene in human breast cancers","volume":"241","author":"Lee","year":"1988","journal-title":"Science"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0300","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.3175651","article-title":"Structural rearrangement of the retinoblastoma gene in human breast carcinoma","volume":"242","author":"TAng","year":"1988","journal-title":"Science"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0305","first-page":"2991","article-title":"The retinoblastoma gene in breast cancer: Allele loss is not correlated with loss of gene product expression","volume":"52","author":"Borg","year":"1992","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0310","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/0046-8177(92)90059-C","article-title":"Retinoblastoma and p53 gene product expression in breast carcinoma: Immunohistochemical analysis and clinicopathological correlation","volume":"23","author":"Trudel","year":"1992","journal-title":"Hum Pathol"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0315","doi-asserted-by":"crossref","first-page":"7304","DOI":"10.1073\/pnas.86.18.7204","article-title":"Loss of heterozygosity on chromosome 1q in human breast cancer","volume":"86","author":"Chen","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0320","first-page":"73","article-title":"Distal deletion of chromosome 1p in ductal carcinoma of the breast","volume":"45","author":"Genuardi","year":"1989","journal-title":"Am J Hum Genet"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0325","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/ijc.2910450309","article-title":"The locus of the polymorphic epithelial mucin (PEM) tumour antigen on chromosome 1q21 shows a high frequency of alteration in primary human breast tumours","volume":"45","author":"Gendler","year":"1990","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0330","first-page":"1020","article-title":"Frequent somatic imbalance of marker alleles for chromosome 1 in human primary breast carcinoma","volume":"51","author":"Devilee","year":"1991","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0335","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/gcc.2870050406","article-title":"Chromosome 1 alterations in breast cancer: Allele loss on lp and lq is related to lymphogenic metastases and poor prognosis","volume":"5","author":"Borg","year":"1992","journal-title":"Genes Chrom Cancer"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0340","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1093\/jnci\/81.23.1815","article-title":"Presence of two members of c-erbA receptor gene family (c-erbA\u03b2 and c-erbA2) in smallest region of somatic homozygosity on chromosome 3p21\u2013p25 in human breast carcinoma","volume":"81","author":"Ali","year":"1989","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0345","first-page":"1643","article-title":"The human prohibitin gene located on chromosome 17q21 is mutated in sporadic breast cancer","volume":"52","author":"Sato","year":"1992","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0350","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1159\/000133722","article-title":"Report of the committee on chromosome and gene loss in human neoplasia","volume":"58","author":"Seizinger","year":"1991","journal-title":"Cytogenet Cell Genet"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0355","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/gcc.2870060304","article-title":"Interstitial deletion of the short arm of chromosome-3 as a primary chromosome abnormality in carcinomas of the breast","volume":"6","author":"Pandis","year":"1993","journal-title":"Genes Chrom Cancer"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0360","first-page":"1705","article-title":"Allelotype of human breast carcinoma: A second major site for loss of heterozygosity is on chromosome 6q","volume":"6","author":"Devilee","year":"1991","journal-title":"Oncogene"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0365","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1126\/science.3659909","article-title":"Reduction to homozygosity of genes on chromosome 11 in human breast neoplasia","volume":"238","author":"Ali","year":"1987","journal-title":"Science"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0370","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/bjc.1988.295","article-title":"Partial deletion of chromosome 11p in breast cancer correlates with size of primary tumour and oestrogen receptor level","volume":"58","author":"Mackay","year":"1988","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0375","doi-asserted-by":"crossref","first-page":"7737","DOI":"10.1073\/pnas.87.19.7737","article-title":"Loss of heterozygosity on chromosomes 17 and 18 in breast carcinoma: Two additional regions identified","volume":"87","author":"Cropp","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0955-2235(92)90002-Y","article-title":"The type 1 (EGF receptor-related) family of growth factor receptors and their ligands","volume":"4","author":"Prigent","year":"1992","journal-title":"Prog Growth Factor Res"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0385","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1126\/science.256.5060.1205","article-title":"Identification of heregulin, a specific activator of p185-erbB2","volume":"256","author":"Holmes","year":"1992","journal-title":"Science"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0390","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0092-8674(92)90131-U","article-title":"Isolation of the NEU\/ HER-2 stimulating ligand - a 44 KD glycoprotein that induces differentiation of mammary rumour cells","volume":"69","author":"Peles","year":"1992","journal-title":"Cell"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0395","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/0092-8674(92)90456-M","article-title":"Neu differentiation factor A transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit","volume":"69","author":"Wen","year":"1992","journal-title":"Cell"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0400","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1126\/science.2992089","article-title":"Amplification of a novel v-erbB-related gene in a human mammary carcinoma","volume":"229","author":"King","year":"1985","journal-title":"Science"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0405","series-title":"Genes, oncogenes and hormones: Advances in cellular and molecular biology of breast cancer","first-page":"161","article-title":"c-erbB-2 amplification and overexpression in human rumours","author":"Lofts","year":"1991"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0410","series-title":"Cancer surveys 16: The molecular pathology of cancer","first-page":"31","article-title":"The molecular pathology of human breast cancer","author":"Walker","year":"1993"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0415","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/ijc.2910420608","article-title":"Immunohistochemical distribution of c-erbB-2 in infiltrating and in situ breast cancer","volume":"42","author":"Gusterson","year":"1988","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0420","first-page":"1239","article-title":"neu-protein overexpression in breast cancer Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer","volume":"319","author":"van der Vijver","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0425","first-page":"6701","article-title":"Increased erbB-2 gene copies and expression in multiple stages of breast cancer","volume":"50","author":"Iglehart","year":"1990","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0430","first-page":"1027","article-title":"The HER2 (c-erbB-2) oncogene is frequently amplified in in situ carcinomas of the breast","volume":"7","author":"Liu","year":"1992","journal-title":"Oncogene"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0435","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1126\/science.2470152","article-title":"Studies of the HER-2\/neu proto-oncogene in human breast and ovarian cancer","volume":"244","author":"Slamon","year":"1989","journal-title":"Science"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0440","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/bjc.1989.299","article-title":"An evaluation of immuno-reactivity for c-erbB-2 protein as a marker of poor short-term prognosis in breast cancer","volume":"60","author":"Walker","year":"1989","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0445","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1200\/JCO.1989.7.8.1120","article-title":"HER-2\/neu oncogene protein and prognosis in breast cancer","volume":"7","author":"Tandon","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0450","first-page":"4332","article-title":"HER-2\/neu amplification predicts poor survival in node-positive breast cancer","volume":"50","author":"Borg","year":"1990","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0455","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/bjc.1991.100","article-title":"c-erbB-2 protein over-expression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes","volume":"63","author":"Gullick","year":"1991","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0460","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/bjc.1991.101","article-title":"c-erbB-2 oncoprotein expression in primary and advanced breast cancer","volume":"63","author":"Lovekin","year":"1991","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0465","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/bjc.1991.103","article-title":"The long term prognostic significance of c-erbB-2 in primary breast cancer","volume":"63","author":"Winstanley","year":"1991","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0470","first-page":"556","article-title":"Correlation between c-erbB-2 amplification and risk of recurrent disease in node negative breast cancer","volume":"51","author":"Paterson","year":"1991","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0475","first-page":"350","article-title":"Association of c-ERBB-2 oncoprotein expression with lack of response to endocrine therapy in recurrent breast cancer","volume":"158","author":"Wright","year":"1989","journal-title":"J Pathol"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0480","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/path.1711630205","article-title":"Long-term survival in breast cancer related to over-expression of the c-ERBB-2 oncoprotein \u2013 an immunohistochemical study using monoclonal antibody NCL-CB11","volume":"163","author":"Dykin","year":"1991","journal-title":"J Pathol"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0485","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/bjc.1992.22","article-title":"Relationship between c-ERBB-2 protein product expression and response to therapy in advanced breast cancer","volume":"65","author":"Wright","year":"1992","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0490","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1200\/JCO.1992.10.7.1049","article-title":"Prognostic importance of c-ERBB-2 expression in breast cancer","volume":"10","author":"Gusterson","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0495","first-page":"5361","article-title":"Requirements for the internalization of a murine monoclonal antibody directed against the Her-2\/neu gene product c-erbB-2","volume":"51","author":"Maier","year":"1991","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0500","first-page":"6832","article-title":"In vitro cytotoxic targeting by human monoclonal cells and bispecific antibody 2B1, recognising c-erbB-2 proto-oncogene product and Fc-gamma receptor m","volume":"52","author":"Hsieh-Ma","year":"1992","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0505","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/ijc.2910500523","article-title":"Human c-erbB-2 proto-oncogene product is a target for bispecific antibody directed adoptive tumour immunotherapy","volume":"50","author":"Nishimura","year":"1992","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0510","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1349-7006.1992.tb00126.x","article-title":"In vitro antitumour activity of anti-c-erbB-2 anti-cd3-epsilon bifunctional monoclonal antibody","volume":"83","author":"Sugiyama","year":"1992","journal-title":"Jpn J Cancer Res"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0515","first-page":"6310","article-title":"Selective inhibition of tumour cell growth by a recombinant single chain antibody toxin specific for the erbB-2 receptor","volume":"52","author":"Wels","year":"1992","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0520","first-page":"4575","article-title":"A monoclonal-antibody against the c-erbB-2 protein enhances the cytotoxicity of cis-diamminedichloroplatinum against human breast and ovarian tumour cell lines","volume":"51","author":"Hancock","year":"1991","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0525","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1021\/jm00110a022","article-title":"Heterocyclic and alpha substituted benziledenemalononitrile tryphostins as potent inhibitors of EGF receptor and erbB-2\/ neu protein kinases","volume":"34","author":"Gazit","year":"1991","journal-title":"J Med Chem"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0530","first-page":"29","article-title":"Antisense cDNA inhibits neu oncogene expression in mammary cells","volume":"15D","author":"De Bortoli","year":"1991","journal-title":"J Cell Biochem"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0535","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1002\/j.1460-2075.1993.tb05891.x","article-title":"A novel transcription factor, OB2-1, is required for overexpression of the proto-oncogene c-erbB-2 in mammary tumour lines","volume":"12","author":"Hollywood","year":"1993","journal-title":"EMBO J"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0540","first-page":"1001","article-title":"Inhibition of c-erbB-2 expression by oestrogens in human breast cancer cells","volume":"5","author":"Dati","year":"1990","journal-title":"Oncogene"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0545","first-page":"431","article-title":"Decrease in c-erbB-2 and c-myc RNA levels in tamoxifen-treated breast cancer","volume":"6","author":"Le Roy","year":"1991","journal-title":"Oncogene"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0550","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1073\/pnas.88.9.3520","article-title":"Efficient immortalisation of luminal epithelial cells from the human mammary gland by introduction of SV40 large T antigen by recombinant retrovirus","volume":"88","author":"Bartek","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0555","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/ijc.2910450620","article-title":"Selective immortalisation of a phenotypically distinct epithelial cell type by microinjection of SV40 DNA into cultured human milk cells","volume":"45","author":"Bartek","year":"1993","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0560","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0014-4827(91)90364-Z","article-title":"Morphological differentiation of hybrids of human mammary epithelial cell lines is dominant and correlates with the pattern of expression of intermediate filaments","volume":"194","author":"Berdichevsky","year":"1991","journal-title":"Exp Cell Res"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0565","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1242\/jcs.102.3.437","article-title":"Collagen-induced rapid morphogenesis of human mammary epithelial cells: The role of the alpha2 \u03b21 integrin","volume":"102","author":"Berdichevsky","year":"1992","journal-title":"J Cell Science"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0570","series-title":"Cancer surveys 16: The molecular pathology of cancer","first-page":"59","article-title":"Human models of breast cancer","author":"Taylor-Papadimitriou","year":"1993"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0575","first-page":"1797","article-title":"Collagen-induced morphogenesis and expression of the alpha2-integrin subunit is inhibited in c-erbB-2-transfected human mammary epithelial cells","volume":"8","author":"D\u2019Souza","year":"1993","journal-title":"Oncogene"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0580","series-title":"Molecular pathology of cancer","first-page":"96","article-title":"Transgenic mouse models of mammary tumorigenesis","author":"Cardiff","year":"1993"},{"key":"10.1093\/annonc\/5.suppl_4.S31_bb0585","series-title":"Molecular pathology of cancer","first-page":"79","article-title":"Tissue reconstruction models of breast cancer","author":"Edwards","year":"1993"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341963454X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341963454X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/5\/suppl_4\/S31\/6679285\/5-suppl_4-S31.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T17:18:10Z","timestamp":1643649490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092375341963454X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994]]},"references-count":106,"alternative-id":["S092375341963454X"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/5.suppl_4.s31","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[1994]]}}}